Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1701

1.

Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.

Kagan R, Abreu P, Andrews E.

Postgrad Med. 2018 Nov;130(8):687-693. doi: 10.1080/00325481.2018.1520046. Epub 2018 Oct 3.

PMID:
30280946
3.

Efficacy Of 17- Α-Hydroxy-Progestrone In Prevention Of Preterm Labour In High Risk Pregnant Women.

Shadab W, Riaz S, Aftab F, Shah FH.

J Ayub Med Coll Abbottabad. 2018 Apr-Jun;30(2):209-212.

4.

Multiples of Median-Transformed, Normalized Reference Ranges of Steroid Profiling Data Independent of Age, Sex, and Units.

Zalas D, Reinehr T, Niedziela M, Borzikowsky C, Flader M, Simic-Schleicher G, Akkurt HI, Heger S, Hornig N, Holterhus PM, Kulle AE.

Horm Res Paediatr. 2018;89(4):255-264. doi: 10.1159/000488028. Epub 2018 Apr 25.

PMID:
29694956
5.

A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.

Shambhavi S, Bagga R, Bansal P, Kalra J, Kumar P.

J Obstet Gynaecol. 2018 Aug;38(6):800-806. doi: 10.1080/01443615.2018.1425380. Epub 2018 Mar 20.

PMID:
29557230
6.

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.

Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Dal Santo L, Ngwira B.

Lancet Glob Health. 2018 May;6(5):e568-e578. doi: 10.1016/S2214-109X(18)30061-5. Epub 2018 Mar 8.

7.

New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.

Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, Quan X, Lyu Q, Kuang Y, Ai A.

Hum Reprod. 2018 Feb 1;33(2):229-237. doi: 10.1093/humrep/dex367.

PMID:
29300975
9.

Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial.

Singata-Madliki M, Hofmeyr GJ, Carayon-Lefebvre d'Hellencourt F, Lawrie TA.

BMJ Open. 2017 Nov 12;7(11):e019205. doi: 10.1136/bmjopen-2017-019205.

10.

Estrus resynchronization in ewes with unknown pregnancy status.

Miranda VO, Oliveira FC, Dias JH, Vargas Júnior SF, Goularte KL, Sá Filho MF, Sá Filho OG, Baldassarre H, Vieira AD, Lucia T Jr, Gasperin BG.

Theriogenology. 2018 Jan 15;106:103-107. doi: 10.1016/j.theriogenology.2017.10.019. Epub 2017 Oct 10.

11.

Why Didn't You Text Me? Poststudy Trends From the DepoText Trial.

Buchanan CRM, Tomaszewski K, Chung SE, Upadhya KK, Ramsey A, Trent ME.

Clin Pediatr (Phila). 2018 Jan;57(1):82-88. doi: 10.1177/0009922816689674. Epub 2017 Feb 13.

12.

Twin transvaginal cervical length at 16-20 weeks and prediction of preterm birth.

Hester AE, Ankumah NE, Chauhan SP, Blackwell SC, Sibai BM.

J Matern Fetal Neonatal Med. 2019 Feb;32(4):550-554. doi: 10.1080/14767058.2017.1384806. Epub 2017 Oct 8.

PMID:
28942691
13.

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.

Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J; WHI Investigators.

JAMA. 2017 Sep 12;318(10):927-938. doi: 10.1001/jama.2017.11217.

14.

Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.

Chen Q, Wang Y, Sun L, Zhang S, Chai W, Hong Q, Long H, Wang L, Lyu Q, Kuang Y.

Reprod Biol Endocrinol. 2017 Sep 5;15(1):71. doi: 10.1186/s12958-017-0291-0.

15.

The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.

Uysal G, Acmaz G, Madendag Y, Cagli F, Akkaya H, Madendag I, Karakilic EU.

Gynecol Obstet Invest. 2018;83(2):151-155. doi: 10.1159/000477618. Epub 2017 Jul 15.

PMID:
28715800
16.

Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy.

Lantto H, Haapalahti P, Viitasalo M, Väänänen H, Sovijärvi ARA, Ylikorkala O, Mikkola TS.

Menopause. 2017 Dec;24(12):1386-1391. doi: 10.1097/GME.0000000000000932.

PMID:
28697043
17.

Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.

Facchinetti F, Vergani P, Di Tommaso M, Marozio L, Acaia B, Vicini R, Pignatti L, Locatelli A, Spitaleri M, Benedetto C, Zaina B, DʼAmico R.

Obstet Gynecol. 2017 Jul;130(1):64-70. doi: 10.1097/AOG.0000000000002065.

PMID:
28594783
18.

The effect of omega-3 supplementation on pregnancy outcomes by smoking status.

Kuper SG, Abramovici AR, Jauk VC, Harper LM, Biggio JR, Tita AT.

Am J Obstet Gynecol. 2017 Oct;217(4):476.e1-476.e6. doi: 10.1016/j.ajog.2017.05.033. Epub 2017 May 23.

19.

Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.

Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K, Nair G, Chappell C, Kiweewa FM, Kabwigu S, Naidoo L, Jeenarain N, Marzinke M, Soto-Torres L, Brown ER, Baeten JM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e47-e51. doi: 10.1097/QAI.0000000000001455.

20.

Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.

Ran SY, Yu Q, Chen Y, Lin SQ.

Climacteric. 2017 Aug;20(4):391-396. doi: 10.1080/13697137.2017.1325459. Epub 2017 May 19.

PMID:
28523945

Supplemental Content

Loading ...
Support Center